comparemela.com

Gossamer Bio, Inc. (NASDAQ:GOSS – Get Free Report) has earned a consensus recommendation of “Hold” from the six research firms that are covering the company, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 1-year target price among […]

Related Keywords

Hong Kong ,California ,United States ,Bryan Giraudo ,Gossamer Bio Company Profile ,Invesco Ltd ,Hong Kong Ltd ,Nasdaq ,Securities Exchange Commission ,Gossamer Bio Inc ,Gossamer Bio ,Get Free Report ,Exchange Commission ,State Teachers Retirement System ,Street Group ,Kong Ltd ,Get Free ,Tyrosine Kinase ,Gossamer Bio Daily ,Nasdaq Goss ,Goss ,Medical ,Ratings ,Consensus ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.